Innovative Molecular Detection System Offers On-Site and Rapid Detection of SARS-CoV-2
|
By LabMedica International staff writers Posted on 13 Jan 2021 |
|
Illustration
A compact and robust molecular detection system based on the isothermal DNA/RNA amplification method can provide on-site and rapid detection of SARS-CoV-2, making it ideal for use in airports, sport venues, pharmacies and workplaces due to its simple and fast operation procedure.
The eGGi molecular detection system developed by Winnoz Technology (Taipei, Taiwan) offers an on-site and rapid screening solution for the SARS-CoV-2 virus. By using saliva or swab specimens as sampling and without RNA extraction, the test result can be finalized in 40 minutes for anyone and anywhere. Unlike a central lab model, the eGGi point-of-care testing solution can be applied and deployed quickly, making it more cost-effective and time saving.
In addition to the eGGi molecular detection system, Winnoz also offers a vacuum assisted fingertip blood collection system named Haiim that is bundled with various testing kits to identify COVID-19 infection. The rapid screening test results can help medical staff to quickly identify the illness and proceed with appropriate treatments. The portable automatic vacuum assisted fingertip blood micro collection device is extremely efficient in comparison to current methods such as needles. The blood collected using Haiim is of sufficient volume to meet the requirements of many testing strips and requires minimal training to operate. Haiim can be applied within COVID-19 vaccine efficacy test sampling, as the blood specimen can be collected at home and sent to laboratories for testing, thus reducing the risk.
"We believe that the COVID-19 screening and vaccination efficacy test would play a more important role as vaccines roll out to bring our life back to normal." said Dr. Joses Hsiung, Winnoz Founder and CEO. "The advent of new technologies and innovations because of the challenges of the ongoing pandemic will push the global healthcare ecosystem to new boundaries. For example, how to deploy and roll out the screening, vaccines and vaccine efficacy testing quickly would be very crucial. eGGi, a rapid and on-site isothermal PCR, is able to support screening for anyone and anywhere, meanwhile Haiim, a unique blood microsampling solution, makes vaccine efficacy test sampling easier and safer."
Related Links:
Winnoz Technology
The eGGi molecular detection system developed by Winnoz Technology (Taipei, Taiwan) offers an on-site and rapid screening solution for the SARS-CoV-2 virus. By using saliva or swab specimens as sampling and without RNA extraction, the test result can be finalized in 40 minutes for anyone and anywhere. Unlike a central lab model, the eGGi point-of-care testing solution can be applied and deployed quickly, making it more cost-effective and time saving.
In addition to the eGGi molecular detection system, Winnoz also offers a vacuum assisted fingertip blood collection system named Haiim that is bundled with various testing kits to identify COVID-19 infection. The rapid screening test results can help medical staff to quickly identify the illness and proceed with appropriate treatments. The portable automatic vacuum assisted fingertip blood micro collection device is extremely efficient in comparison to current methods such as needles. The blood collected using Haiim is of sufficient volume to meet the requirements of many testing strips and requires minimal training to operate. Haiim can be applied within COVID-19 vaccine efficacy test sampling, as the blood specimen can be collected at home and sent to laboratories for testing, thus reducing the risk.
"We believe that the COVID-19 screening and vaccination efficacy test would play a more important role as vaccines roll out to bring our life back to normal." said Dr. Joses Hsiung, Winnoz Founder and CEO. "The advent of new technologies and innovations because of the challenges of the ongoing pandemic will push the global healthcare ecosystem to new boundaries. For example, how to deploy and roll out the screening, vaccines and vaccine efficacy testing quickly would be very crucial. eGGi, a rapid and on-site isothermal PCR, is able to support screening for anyone and anywhere, meanwhile Haiim, a unique blood microsampling solution, makes vaccine efficacy test sampling easier and safer."
Related Links:
Winnoz Technology
Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
New
Bordetella Pertussis Molecular Assay
Alethia Pertussis
New
H.pylori Test
Humasis H.pylori Card
Latest COVID-19 News
- New Immunosensor Paves Way to Rapid POC Testing for COVID-19 and Emerging Infectious Diseases
- Long COVID Etiologies Found in Acute Infection Blood Samples
- Novel Device Detects COVID-19 Antibodies in Five Minutes
- CRISPR-Powered COVID-19 Test Detects SARS-CoV-2 in 30 Minutes Using Gene Scissors
- Gut Microbiome Dysbiosis Linked to COVID-19
- Novel SARS CoV-2 Rapid Antigen Test Validated for Diagnostic Accuracy
- New COVID + Flu + R.S.V. Test to Help Prepare for `Tripledemic`
- AI Takes Guesswork Out Of Lateral Flow Testing
- Fastest Ever SARS-CoV-2 Antigen Test Designed for Non-Invasive COVID-19 Testing in Any Setting
- Rapid Antigen Tests Detect Omicron, Delta SARS-CoV-2 Variants
- Health Care Professionals Showed Increased Interest in POC Technologies During Pandemic, Finds Study
- Set Up Reserve Lab Capacity Now for Faster Response to Next Pandemic, Say Researchers
- Blood Test Performed During Initial Infection Predicts Long COVID Risk
- Low-Cost COVID-19 Testing Platform Combines Sensitivity of PCR and Speed of Antigen Tests
- Finger-Prick Blood Test Identifies Immunity to COVID-19
- Quick Test Kit Determines Immunity Against COVID-19 and Its Variants
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read more
Molecular Diagnostics
view channel
Simple Blood Test Improves Heart Attack and Stroke Risk Prediction
Troponin is a protein found in heart muscle cells that is released into the bloodstream when the heart is damaged. High-sensitivity troponin blood tests are commonly used in hospitals to diagnose heart... Read more
Blood Biomarker Test Could Detect Genetic Predisposition to Alzheimer’s
New medications for Alzheimer’s disease, the most common form of dementia, are now becoming available. These treatments, known as “amyloid antibodies,” work by promoting the removal of small deposits from... Read more
Novel Autoantibody Against DAGLA Discovered in Cerebellitis
Autoimmune cerebellar ataxias are strongly disabling disorders characterized by an impaired ability to coordinate muscle movement. Cerebellar autoantibodies serve as useful biomarkers to support rapid... Read more
Gene-Based Blood Test Accurately Predicts Tumor Recurrence of Advanced Skin Cancer
Melanoma, an aggressive form of skin cancer, becomes extremely difficult to treat once it spreads to other parts of the body. For patients with metastatic melanoma tumors that cannot be surgically removed... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read more
Immunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read more
Microbiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Pathology
view channel
Spit Test More Accurate at Identifying Future Prostate Cancer Risk
Currently, blood tests that measure the level of a protein called prostate-specific antigen (PSA) are commonly used to identify men at higher risk for prostate cancer. This test is typically used based... Read more
DNA Nanotechnology Boosts Sensitivity of Test Strips
Since the Covid-19 pandemic, most people have become familiar with paper-based rapid test strips, also known as lateral flow immunoassays (LFIAs). These tests are used to quickly detect biomarkers that... Read more
Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures
Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more
Technology
view channel
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read more
Industry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more
